Skip to main content

Point72 Asset Management, L.P.

Position in MYGN — Myriad Genetics Inc

CIK 1603466 STAMFORD, CT

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,310,554
-$3,270,354 QoQ
Shares Held
957,901
-22.3% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Derivatives in MYGN

reported options exposure · as of Jun 30, 2025
CallValue
$2,124,000
CallShares
400,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $770,084,185 across 21 Diagnostics & Research names. MYGN ranks #15 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,310,554 957,901
2025-12-31 $7,580,908 1,232,668
2025-09-30 $7,764,752 1,073,963
2025-06-30 $2,124,000 400,000
2025-06-30 $2,857,098 538,060
2025-03-31 $1,640,950 185,000
2024-12-31 $4,779,360 348,604
2024-09-30 $29,135,044 1,063,711
2024-06-30 $20,533,093 839,456
2024-03-31 $16,591,138 778,196
2023-09-30 $42,281 2,636
2023-06-30 $811 35
2022-12-31 $388,868 26,800
2022-09-30 $7,716,104 404,408
2022-06-30 $4,165,381 229,245
2022-03-31 $3,719,444 147,597
2021-09-30 $7,733,228 239,493
2021-06-30 $11,675,596 381,805
2021-03-31 $12,114,471 397,848
2020-12-31 $7,297,265 369,108
2020-09-30 $313,990 24,079
2020-03-31 $2,024,865 141,500